![](/img/cover-not-exists.png)
PCN99 THE COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF RITUXIMAB(HANLIKANG) FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA
Zhao, M.M., Xiang, Y., Juying, W., Jia, S.H., Chen, B.B., Fan, C.S.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.296
Date:
November, 2019
File:
PDF, 382 KB
2019